Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Hospitalization Risk from Onglyza Heart Failure Questioned in New Study August 3, 2015 Irvin Jackson Add Your Comments Although an FDA advisory panel recently called for stronger warnings about potential Onglyza heart failure risks, the manufacturer of the diabetes drug has presented data that appears to question whether there is a link. At a meeting of the American Diabetes Association (ADA) in June, research was presented by AstraZeneca that found no evidence that users face an increased risk of hospitalization from heart failure while using Onglyza. The review of data from an observational, retrospective insurance claims database study has not yet been published for peer review. Onglyza (saxagliptin) was developed jointly by AstraZeneca and Bristol-Myers Squibb, but is now owned wholly by AstraZeneca. It was approved by the FDA in July 2009, for treatment of type 2 diabetes, and the medication is part of a class of drugs known as incretin mimetics, which also includes Januvia, Janumet, Byetta, Victoza and other widely used medications. Learn More About Onglyza Lawsuit Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Onglyza Lawsuit Learn More SEE IF YOU QUALIFY FOR COMPENSATION In April, the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted 14-1 to recommend stronger warnings about the potential Onglyza heart risks, after a review of data from clinical trials suggested that users may face a higher than expected risk of hospitalization for heart failure and all-cause mortality. At issue is data collected from a clinical trial known as SAVOR, which involved 16,492 subjects with type 2 diabetes, some of whom were given Onglyza, and some of whom were given a placebo. AstraZeneca indicated in a recent press release that the new analysis used real world data from an insurance claims database to compare Ongylza use with those that use the diabetes drug Januvia, and a class of drugs known as sulfonylureas, such as metformin, Micronase and DiaBeta. Researchers found that Onglyza and Januvia had lower risks of hospitalization for heart failure than those given sulfonylureas, and could find no increased risk of heart failure when comparing Onglyza and Januvia to slufonylureas, or when comparing Onglyza to Januvia. FDA reviewers previously indicated that the SAVOR results suggested that there may be a 27% increased risk of heart failure hospitalization on Onglyza. They also found both increases in cardiovascular death and death from all causes. The FDA’s advisory committee had several possible options, including new label warnings, limiting Onglyza’s availability, or recommending an Onglyza recall. In the end, only one committee member voted for a recall. The other 14 called for new label warnings. While the agency has not yet acted on the recommendations, the FDA usually follows the guidance of their advisory committees. Onglyza is a DPP-4 inhibitor, which is part of a class of drugs known as incretin mimetics that works by mimicking the incretin hormones the body usually produces to naturally stimulate the release of insulin in response to a meal. The diabetes drug brought in more than $700 million in sales in 2012. Other DPP-4 inhibitors include Nesina and Januvia. The FDA launched an investigation into the potential heart risks with Onglyza last year, following the publication of the SAVOR study by the New England Journal of Medicine in 2013. Tags: AstraZeneca, Diabetes, Diabetes Drug, Heart Failure, Januvia, Onglyza More Onglyza Lawsuit Stories Heart Failure Lawsuit Filed Against Makers Of Onglyza November 19, 2018 Judge Splits Discovery in Onglyza Heart Failure Cases Into Two Phases November 1, 2018 Drug Makers Want Plaintiffs To Prove Link Between Onglyza and Heart Failure Before Claims Proceed October 19, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: yesterday) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025) Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: 2 days ago) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025) Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: 2 days ago) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)
Drug Makers Want Plaintiffs To Prove Link Between Onglyza and Heart Failure Before Claims Proceed October 19, 2018
Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: yesterday) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025)
Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: 2 days ago) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)
Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: 2 days ago) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)